Home/Filings/4/0001209191-18-064099
4//SEC Filing

Vertex Pharmaceuticals (Europe) Ltd 4

Accession 0001209191-18-064099

CIK 0001674416other

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 4:35 PM ET

Size

12.4 KB

Accession

0001209191-18-064099

Insider Transaction Report

Form 4
Period: 2018-12-21
Transactions
  • Purchase

    Common Shares

    2018-12-24$22.91/sh+2,603$59,6475,275,345 total
  • Purchase

    Common Shares

    2018-12-21$22.58/sh+22,742$513,4785,272,742 total
  • Purchase

    Common Shares

    2018-12-24$23.18/sh+11,742$272,1405,287,087 total
  • Purchase

    Common Shares

    2018-12-24$24.97/sh+53,655$1,339,6965,340,742 total
Transactions
  • Purchase

    Common Shares

    2018-12-24$22.91/sh+2,603$59,6475,275,345 total
  • Purchase

    Common Shares

    2018-12-21$22.58/sh+22,742$513,4785,272,742 total
  • Purchase

    Common Shares

    2018-12-24$23.18/sh+11,742$272,1405,287,087 total
  • Purchase

    Common Shares

    2018-12-24$24.97/sh+53,655$1,339,6965,340,742 total
Footnotes (5)
  • [F1]Shares are directly held by Vertex Pharmaceuticals (Europe) Limited ("Vertex Europe"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe.
  • [F2]Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.46 and $22.70.
  • [F3]Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.69 and $23.00.
  • [F4]Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.02 and $23.25.
  • [F5]Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.82 and $25.00.

Issuer

CRISPR Therapeutics AG

CIK 0001674416

Entity typeother
IncorporatedUnited Kingdom

Related Parties

1
  • filerCIK 0001761216

Filing Metadata

Form type
4
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 4:35 PM ET
Size
12.4 KB